{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T06:45:38Z","timestamp":1768805138433,"version":"3.49.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Radiat Oncol"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s13014-015-0477-6","type":"journal-article","created":{"date-parts":[[2015,8,12]],"date-time":"2015-08-12T21:10:01Z","timestamp":1439413801000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["French multicentre clinical evaluation of helical TomoTherapy\u00ae for anal cancer in a cohort of 64 consecutive patients"],"prefix":"10.1186","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8627-4616","authenticated-orcid":false,"given":"V.","family":"Vendrely","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Henriques de Figueiredo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Rio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Benech","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Belhomme","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Lisbona","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Frison","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Doussau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Nomikossoff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. A.","family":"Mah\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Kantor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. P.","family":"Maire","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,8,14]]},"reference":[{"key":"477_CR1","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1071\/SH12070","volume":"9","author":"AE Grulich","year":"2012","unstructured":"Grulich AE, Poynten IM, Machalek DA, Jin F, Templeton DJ, Hillman RJ. The epidemiology of anal cancer. Sex Health. 2012;9:504\u20138.","journal-title":"Sex Health"},{"key":"477_CR2","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1002\/cncr.20364","volume":"101","author":"LG Johnson","year":"2004","unstructured":"Johnson LG, Madeleine MM, Newcomer LM, Schwartz SM, Daling JR. Anal cancer incidence and survival: The Surveillance, Epidemiology, and End Results experience, 1973\u20132000. Cancer. 2004;101:281\u20138.","journal-title":"Cancer"},{"key":"477_CR3","first-page":"258","volume":"61","author":"Centers for Disease Control and Prevention (CDC)","year":"2012","unstructured":"Centers for Disease Control and Prevention (CDC). Human papillomavirus-associated cancers - United States, 2004\u20132008. MMWR Morb Mortal Wkly Rep. 2012;61:258\u201361.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"477_CR4","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1002\/ijc.25671","volume":"129","author":"L Abramowitz","year":"2011","unstructured":"Abramowitz L, Jacquard A-C, Jaroud F, Haesebaert J, Siproudhis L, Pradat P, et al. Human papillomavirus genotype distribution in anal cancer in France: the EDiTH V study. Int J Cancer. 2011;129:433\u20139.","journal-title":"Int J Cancer"},{"issue":"9","key":"477_CR5","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1002\/ijc.27650","volume":"131","author":"M Arbyn","year":"2012","unstructured":"Arbyn M, de Sanjos\u00e9 S, Saraiya M, Sideri M, Palefsky J, Lacey C, et al. EUROGIN 2011 roadmap on prevention and treatment of HPV-related disease. Int J Cancer. 2012;131(9):1969\u201382.","journal-title":"Int J Cancer"},{"key":"477_CR6","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1007\/BF02238600","volume":"36","author":"ND Nigro","year":"1993","unstructured":"Nigro ND, Vaitkevicius VK, Considine BJ. Combined therapy for cancer of the anal canal: a preliminary report. 1974. Diseases of the Colon & Rectum. 1993;36:709\u201311.","journal-title":"Diseases of the Colon & Rectum"},{"key":"477_CR7","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.clon.2005.03.008","volume":"17","author":"R James","year":"2005","unstructured":"James R, Meadows H, Wan S. ACT II: the second UK phase III anal cancer trial. Clin Oncol (R Coll Radiol). 2005;17:364\u20136.","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"477_CR8","doi-asserted-by":"crossref","first-page":"4344","DOI":"10.1200\/JCO.2012.43.8085","volume":"30","author":"LL Gunderson","year":"2012","unstructured":"Gunderson LL, Winter KA, Ajani JA, Pedersen JE, Moughan J, Benson AB, et al. Long-term update of US GI intergroup RTOG 98\u201311 phase III trial for anal carcinoma: survival, relapse, and colostomy failure with concurrent chemoradiation involving fluorouracil\/mitomycin versus fluorouracil\/cisplatin. J Clin Oncol. 2012;30:4344\u201351.","journal-title":"J Clin Oncol"},{"key":"477_CR9","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1001\/jama.299.16.1914","volume":"299","author":"JA Ajani","year":"2008","unstructured":"Ajani JA, Winter KA, Gunderson LL, Pedersen J, Benson AB, Thomas CR, et al. Fluorouracil, mitomycin, and radiotherapy vs fluorouracil, cisplatin, and radiotherapy for carcinoma of the anal canal: a randomized controlled trial. JAMA. 2008;299:1914\u201321.","journal-title":"JAMA"},{"key":"477_CR10","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1200\/JCO.1997.15.5.2040","volume":"15","author":"H Bartelink","year":"1997","unstructured":"Bartelink H, Roelofsen F, Eschwege F, Rougier P, Bosset JF, Gonzalez DG, et al. Concomitant radiotherapy and chemotherapy is superior to radiotherapy alone in the treatment of locally advanced anal cancer: results of a phase III randomized trial of the European Organization for Research and Treatment of Cancer Radiotherapy and Gastrointestinal Cooperative Groups. J Clin Oncol. 1997;15:2040\u20139.","journal-title":"J Clin Oncol"},{"key":"477_CR11","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1038\/sj.bjc.6605605","volume":"102","author":"J Northover","year":"2010","unstructured":"Northover J, Glynne-Jones R, Sebag-Montefiore D, James R, Meadows H, Wan S, et al. Chemoradiation for the treatment of epidermoid anal cancer: 13-year follow-up of the first randomised UKCCCR Anal Cancer Trial (ACT I). Br J Cancer. 2010;102:1123\u20138.","journal-title":"Br J Cancer"},{"key":"477_CR12","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1016\/j.ijrobp.2010.07.1995","volume":"81","author":"R Glynne-Jones","year":"2011","unstructured":"Glynne-Jones R, Sebag-Montefiore D, Adams R, McDonald A, Gollins S, James R, et al. \u201cMind the gap--\u201dthe impact of variations in the duration of the treatment gap and overall treatment time in the first UK Anal Cancer Trial (ACT I). Int J Radiat Oncol Biol Phys. 2011;81:1488\u201394.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"477_CR13","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ijrobp.2012.09.023","volume":"86","author":"LA Kachnic","year":"2013","unstructured":"Kachnic LA, Winter K, Myerson RJ, Goodyear MD, Willins J, Esthappan J, et al. RTOG 0529: A Phase 2 Evaluation of Dose-Painted Intensity Modulated Radiation Therapy in Combination With 5-Fluorouracil and Mitomycin-C for the Reduction of Acute Morbidity in Carcinoma of the Anal Canal. Radiat Oncol Biol. 2013;86:27\u201333.","journal-title":"Radiat Oncol Biol"},{"issue":"2","key":"477_CR14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.canrad.2013.12.008","volume":"18","author":"S Servagi-Vernat","year":"2014","unstructured":"Servagi-Vernat S, Giraud P, Fenoglietto P, Azria D, Lisbona A, de La Rochefordiere A, et al. Apport de la RCMI rotationnelle et de la tomoth\u00e9rapie h\u00e9lico\u00efdale dans les cancers pelviens : \u00e9tude dosim\u00e9trique prospective sur 51 patients. Cancer Radiother. 2014;18(2):1\u20138.","journal-title":"Cancer Radiother"},{"key":"477_CR15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1748-717X-9-113","volume":"9","author":"SA Koerber","year":"2014","unstructured":"Koerber SA, Slynko A, Haefner MF, Krug D, Schoneweg C, Kessel K, et al. Efficacy and toxicity of chemoradiation in patients with anal cancer - a retrospective analysis. Radiat Oncol. 2014;9:1\u20138.","journal-title":"Radiat Oncol"},{"key":"477_CR16","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.canrad.2007.09.006","volume":"11","author":"G Kantor","year":"2007","unstructured":"Kantor G, Mah\u00e9 MA, Giraud P, Alapetite C, Durdux C, Fourquet A, et al. \u00c9valuation nationale de la tomoth\u00e9rapie h\u00e9lico\u00efdale: description des indications, des contraintes de dose et des seuils de repositionnement. Cancer \/ Radiother. 2007;11:331\u20137.","journal-title":"Cancer \/ Radiother"},{"key":"477_CR17","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1200\/JCO.2011.35.4837","volume":"30","author":"D Peiffert","year":"2012","unstructured":"Peiffert D, Tournier-Rangeard L, G\u00e9rard J-P, Lemanski C, Fran\u00e7ois E, Giovannini M, et al. Induction Chemotherapy and Dose Intensification of the Radiation Boost in Locally Advanced Anal Canal Carcinoma: Final Analysis of the Randomized UNICANCER ACCORD 03 Trial. J Clin Oncol. 2012;30:1941\u20138.","journal-title":"J Clin Oncol"},{"key":"477_CR18","doi-asserted-by":"crossref","first-page":"3342","DOI":"10.1002\/cncr.25901","volume":"117","author":"JG Bazan","year":"2011","unstructured":"Bazan JG, Hara W, Hsu A, Kunz PA, Ford J, Fisher GA, et al. Intensity-modulated radiation therapy versus conventional radiation therapy for squamous cell carcinoma of the anal canal. Cancer. 2011;117:3342\u201351.","journal-title":"Cancer"},{"issue":"1","key":"477_CR19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.radonc.2008.12.020","volume":"92","author":"A Clivio","year":"2009","unstructured":"Clivio A, Fogliata A, Franzetti-Pellanda A, Nicolini G, Vanetti E, Wyttenbach R, et al. Volumetric-modulated arc radiotherapy for carcinomas of the anal canal: A treatment planning comparison with fixed field IMRT. Radiother Oncol. 2009;92(1):1\u20137.","journal-title":"Radiother Oncol"},{"key":"477_CR20","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.radonc.2009.10.003","volume":"94","author":"KJ Joseph","year":"2010","unstructured":"Joseph KJ, Syme A, Small C, Warkentin H, Quon H, Ghosh S, et al. A treatment planning study comparing helical tomotherapy with intensity-modulated radiotherapy for the treatment of anal cancer. Radiother Oncol. 2010;94:60\u20136.","journal-title":"Radiother Oncol"},{"key":"477_CR21","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/1748-717X-7-45","volume":"7","author":"S Vieillot","year":"2012","unstructured":"Vieillot S, Fenoglietto P, Lemanski C, Moscardo CL, Gourgou S, Dubois J-B, et al. IMRT for locally advanced anal cancer: clinical experience of the Montpellier Cancer Center. Radiat Oncol. 2012;7:45.","journal-title":"Radiat Oncol"},{"key":"477_CR22","doi-asserted-by":"crossref","unstructured":"Franco P, Mistrangelo M, Arcadipane F, Munoz F, Sciacero P, Spadi R, et al. Intensity-Modulated Radiation Therapy with Simultaneous Integrated Boost Combined with Concurrent Chemotherapy for the Treatment of Anal Cancer Patients: 4-Year Results of a Consecutive Case Series. Cancer Invest. 2015.","DOI":"10.3109\/07357907.2015.1028586"},{"key":"477_CR23","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.ijrobp.2010.09.030","volume":"82","author":"LA Kachnic","year":"2012","unstructured":"Kachnic LA, Tsai HK, Coen JJ, Blaszkowsky LS, Hartshorn K, Kwak EL, et al. Dose-Painted Intensity-Modulated Radiation Therapy for Anal Cancer: A Multi-Institutional Report of Acute Toxicity and Response to Therapy. Int J Radiat Oncol Biol Phys. 2012;82:153\u20138.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"477_CR24","doi-asserted-by":"crossref","first-page":"5061","DOI":"10.1200\/JCO.2010.29.1351","volume":"28","author":"E Ben-Josef","year":"2010","unstructured":"Ben-Josef E, Moughan J, Ajani JA, Flam M, Gunderson L, Pollock J, et al. Impact of Overall Treatment Time on Survival and Local Control in Patients With Anal Cancer: A Pooled Data Analysis of Radiation Therapy Oncology Group Trials 87\u201304 and 98\u201311. J Clin Oncol. 2010;28:5061\u20136.","journal-title":"J Clin Oncol"},{"key":"477_CR25","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/S0360-3016(97)00329-5","volume":"39","author":"EC Constantinou","year":"1997","unstructured":"Constantinou EC, Daly W, Fung CY, Willett CG, Kaufman DS, DeLaney TF. Time-dose considerations in the treatment of anal cancer. Radiat Oncol Biol. 1997;39:651\u20137.","journal-title":"Radiat Oncol Biol"},{"key":"477_CR26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1748-717X-7-1","volume":"7","author":"CV Dewas","year":"2012","unstructured":"Dewas CV, Maingon P, Dalban CC, Petitfils AL, Peignaux K, Truc G, et al. Does gap-free intensity modulated chemoradiation therapy provide a greater clinical benefit than 3D conformal chemoradiation in patients with anal cancer? Radiat Oncol. 2012;7:1\u20131.","journal-title":"Radiat Oncol"}],"container-title":["Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13014-015-0477-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,29]],"date-time":"2019-08-29T05:17:16Z","timestamp":1567055836000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.ro-journal.com\/content\/10\/1\/170"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8,14]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["477"],"URL":"https:\/\/doi.org\/10.1186\/s13014-015-0477-6","relation":{},"ISSN":["1748-717X"],"issn-type":[{"value":"1748-717X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,8,14]]},"article-number":"170"}}